Sivik Global Healthcare’s NxStage Medical Inc. NXTM Stock Holding History

Sivik Global Healthcare’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-70,000	Closed	-$1.21M	–	79
2015 Q1	$1.21M	Sell	70,000 -29,700	-30%	-$525K	0.41%	70
2014 Q4	$1.79M	Sell	99,700 -300	-0.3%	-$4.83K	0.72%	57
2014 Q3	$1.31M	Hold	100,000	–	–	0.6%	58
2014 Q2	$1.44M	Hold	100,000	–	–	0.73%	55
2014 Q1	$1.27M	Buy	100,000 +59,428	+146%	+$775K	0.8%	55
2013 Q4	$406K	Buy	+40,572	New	+$461K	0.29%	56

Other funds holding NXTM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

CIP

Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Sivik Global Healthcare's NXTM Position: Q2 2015 in Review

Sivik Global Healthcare sold out of NxStage Medical Inc. (NXTM) in Q2 2015, closing a stake of 70,000 shares — an estimated $1.21M sold.

Sivik Global Healthcare first reported a position in NXTM in Q4 2013 and held it in 6 quarters. The position peaked at $1.79M in Q4 2014. 139 funds tracked by Wall St. Rank hold NXTM as of Q2 2015.

Sivik Global Healthcare reported no remaining NxStage Medical Inc. position as of Q2 2015 after selling out during the quarter.
Sivik Global Healthcare sold 70,000 NxStage Medical Inc. shares in Q2 2015, an estimated $1.21M.
Sivik Global Healthcare first reported a position in NxStage Medical Inc. in Q4 2013 and held it in 6 quarters.
Sivik Global Healthcare's NxStage Medical Inc. position peaked at $1.79M in Q4 2014.
139 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q2 2015.

Based on Sivik Global Healthcare's 13F filing for Q2 2015, filed 6 Jul 2015.